These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 19880135

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy.
    Ware RE, Eggleston B, Redding-Lallinger R, Wang WC, Smith-Whitley K, Daeschner C, Gee B, Styles LA, Helms RW, Kinney TR, Ohene-Frempong K.
    Blood; 2002 Jan 01; 99(1):10-4. PubMed ID: 11756146
    [Abstract] [Full Text] [Related]

  • 3. Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease.
    Badawy SM, Thompson AA, Penedo FJ, Lai JS, Rychlik K, Liem RI.
    Eur J Haematol; 2017 Jun 01; 98(6):608-614. PubMed ID: 28306171
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia.
    Quinn CT, Niss O, Dong M, Pfeiffer A, Korpik J, Reynaud M, Bonar H, Kalfa TA, Smart LR, Malik P, Ware RE, Vinks AA, McGann PT.
    Br J Haematol; 2021 Aug 01; 194(3):617-625. PubMed ID: 34227124
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy.
    Estepp JH, Smeltzer MP, Kang G, Li C, Wang WC, Abrams C, Aygun B, Ware RE, Nottage K, Hankins JS.
    Am J Hematol; 2017 Dec 01; 92(12):1333-1339. PubMed ID: 28913922
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hydroxyurea in children with sickle cell disease in a resource-poor setting: Monitoring and effects of therapy. A practical perspective.
    Nnebe-Agumadu U, Adebayo I, Erigbuem I, James E, Kumode E, Nnodu O, Adekile A.
    Pediatr Blood Cancer; 2021 Jun 01; 68(6):e28969. PubMed ID: 33788390
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
    Sumoza A, de Bisotti R, Sumoza D, Fairbanks V.
    Am J Hematol; 2002 Nov 01; 71(3):161-5. PubMed ID: 12410569
    [Abstract] [Full Text] [Related]

  • 14. A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease.
    Creary SE, Gladwin MT, Byrne M, Hildesheim M, Krishnamurti L.
    Pediatr Blood Cancer; 2014 Jun 01; 61(6):1068-73. PubMed ID: 24436121
    [Abstract] [Full Text] [Related]

  • 15. Measuring hydroxyurea adherence by pharmacy and laboratory data compared with video observation in children with sickle cell disease.
    Creary S, Chisolm D, Stanek J, Neville K, Garg U, Hankins JS, O'Brien SH.
    Pediatr Blood Cancer; 2020 Aug 01; 67(8):e28250. PubMed ID: 32386106
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term use of hydroxyurea for sickle cell anemia.
    Hagar W.
    JAMA; 2003 Aug 13; 290(6):753; author reply 754. PubMed ID: 12915424
    [No Abstract] [Full Text] [Related]

  • 19. Randomized feasibility trial to improve hydroxyurea adherence in youth ages 10-18 years through community health workers: The HABIT study.
    Green NS, Manwani D, Matos S, Hicks A, Soto L, Castillo Y, Ireland K, Stennett Y, Findley S, Jia H, Smaldone A.
    Pediatr Blood Cancer; 2017 Dec 13; 64(12):. PubMed ID: 28643377
    [Abstract] [Full Text] [Related]

  • 20. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.
    Aygun B, Mortier NA, Smeltzer MP, Shulkin BL, Hankins JS, Ware RE.
    Am J Hematol; 2013 Feb 13; 88(2):116-9. PubMed ID: 23255310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.